Millions of women between the ages of 18 and 59 experience one or more types of female sexual dysfunction (FSD) and many of those women don’t know how to increase their sexual desires, and healthy sexual fantasies.
Men rely on Viagra to relieve male erectile dysfunction; men around the world are enjoying sex thanks to a hypertension medication that turned into the most popular prescription sexual enhancement drug ever developed.
Just like Pfizer the pharmaceutical company that developed Viagra, Boehringer Ingelheim has stumbled on another sexual enhancement drug that has the potential of changing the lives of millions of women who suffer from hypoactive sexual desire disorder, sexual arousal disorder, orgasmic disorder, and sexual pain disorder.
Flibanserin was originally developed as an anti-depressant by Boehringer, but early clinical tests on two thousand women in over two hundred different locations showed that 100mg of Flibanserin taken daily for at least twenty four weeks can increase sexual desires as well as sexual activity in pre-menopausal women.
The data compiled in several clinical tests show that Flibanserin results exceed the expectations of the women participating in the trials. Based on the Flibanserin results of all four clinical studies Boehringer has requested FDA approval so Flibanserin can be purchased by prescription.
No one is exactly sure how these Flibanserin results manifest, but some medical professionals say that the dopamine D4 receptor and the serotonin 5-HT receptor stimulate dopamine and reduces serotonin and that combination impacts the brain as well as the central nervous system, so natural sexual hormone production increases.
Flibanserin results are not from synthetic hormonal ingredients like other prescription medications, but the two agents in Flibanserin play an important role in activating natural sexual hormones.
Flibanserin Results Do Include Some Side Effects
Prescription drugs and side effects go hand-in-hand and the Flibanserin results show that side effects can manifest in some women with FSD symptoms, but they are considered minor by some of the women who experienced Flibanserin results.